Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Learn how to identify crypto coins to hold long term based on fundamentals, use cases, and risk tolerance. Build a resilient, diversified portfolio with smart criteria.
28,040 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
As Lumentum and Coherent rally, Onto Innovation could be the next optics supplier to gain. Analysts say the surge ref...
As gold prices stabilize after a broad correction, two gold mining stocks poised for a rebound are drawing fresh inte...
FuboTV has faced a brutal stretch, yet new synergies from Disney and Hulu may set up a rebound in EBITDA and subscrib...
Markets react to a surprising Air Force One seat allocation featuring Nvidia’s CEO, sparking chatter that export lice...
Jet fuel costs have dropped, yet airfares stay high as demand, hedges, and fees keep tickets elevated. Travelers face...
February can feel like a shifting tide for the S&P 500. This guide shares how to invest smartly this month with a cle...
Awards shine briefly, but investors chase cash flow, growth, and disciplined capital allocation. This guide shows how...
When a well-known TV host shares an aggressive cancer diagnosis, it highlights the financial realities many face afte...
The Virtus InfraCap U.S. Preferred Stock ETF trades near $21 with a 9.9% forward yield built on leverage and high-cou...
Netflix walked away from a blockbuster deal, yet it still raised prices. This personal-finance guide explains what ha...
Inflation soaring again, this under-the-radar ETF is quietly drawing interest from investors seeking an edge against ...